Fenimore Christopher R.
Fenimore Christopher R., EFC, reported a transaction classified as exercise at REGENERON PHARMACEUTICALS, INC. involving 6283.000000 shares for an estimated $2399603.36. Reported holdings after the transaction were 24583.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Aug 18, 2026
- Filing date
- Aug 20, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
REGN price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001697422-26-000002 Common Stock
- Transaction date
- Aug 18, 2026 Filed Aug 20, 2026, 08:01 PM · 2d delay
- Shares
- 6,283 sh $381.92 per share
- Estimated value
- $2.39M Computed from shares × price
- Holdings after
- 24,583 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+10 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
EVP Finance CFO
- F1
These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
- F2
The stock option award vested in four equal annual installments, commencing one year after the date of grant.
0 other transactions
0 recent txs